EANO considers the preparation of multidisciplinary guidelines as a prime task to support the development of high quality care of brain tumor patients across Europe. The decision to generate or update a guideline is made by the EANO Executive Board.
Neuro-Oncology is the major journal in our field (impact factor of 7.786). It is owned by our partner society, Society of Neuro-Oncology in the US, and published by Oxford University Press (OUP). EANO has engaged in a contract with SNO to assure that EANO members have free access to this journal.
Neuro-oncology Practice is a new journal with a different scope as illustrated by its title. It focuses on the clinical aspects of the subspecialty for practicing clinicians and healthcare specialists from a variety of disciplines. Effective 2016, this journal is co-owned by SNO, EANO and OUP.
The EANO magazine has transitioned into a World Federation of Neuro-oncology Societies (WFNOS) magazine in 2016 and is co-edited by EANO and SNO and also published by OUP. Its focus is on hot topics in neuro-oncology disclosed and discussed by WFNOS charter and memberhsip societies.
EANO believes that the neuro-oncology community is served best by this set of publications: bridging experimental and clinical research, addressing practical issues of clinical neuro-oncology, and rapid updates on major developments in our field at all levels.